Basel Medical Group Ltd (BMGL) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Basel Medical Group Ltd (NASDAQ:BMGL) is held by 10 institutional firms.

• Basel Medical Group saw its institutional ownership percentage rose to 1.6% in September 2025 from 0.7% in June 2025.
• Quarterly data indicates a 709.94% shift in institutional share volume, and the annual owner count reflects an unavailable change.
• During the quarter, 10 institutions bought more Basel Medical Group shares, 0 sold shares, and 0 of the 10 total investors held their position steady.
• Collectively, institutional investors increased their stake in Basel Medical Group to 289.52K shares as of September 2025, a change that is up by 253.78K shares quarter on quarter and down N/A shares year over year.
• CITADEL ADVISORS LLC's holding of 93.00K shares as of September 30, 2025 makes it the primary institutional investor in Basel Medical Group, owning 0.50% of the stock.
• Among the most significant buyers of Basel Medical Group during September 2025 were CITADEL ADVISORS LLC (93.00K), MORGAN STANLEY (74.29K), Marex Group plc (44.99K), Vanguard Personalized Indexing Management, LLC (22.11K), Virtu Financial LLC (17.61K).
• The top 10 institutional holders of Basel Medical Group for the quarter ending September 2025 included CITADEL ADVISORS LLC (93.00K), MORGAN STANLEY (74.29K), Marex Group plc (58.91K), Virtu Financial LLC (33.79K), Vanguard Personalized Indexing Management, LLC (22.11K), UBS Group AG (5.90K), WealthCollab, LLC (953), EverSource Wealth Advisors, LLC (277), Bell Investment Advisors, Inc (248), Coston, McIsaac & Partners (50).